Registration gives the benefit of site update e-mails and additional information from Takeda on new education materials and events.
ADHD Institute Register

The Meeting of Minds series, now in its 10th year, is an invitation-only meeting developed in collaboration with a group of global experts in attention-deficit hyperactivity disorder (ADHD) in order to organise a programme that aims to meet the educational needs of clinicians involved in the management of ADHD and research scientists.

The Meeting of Minds programme examined the advances in science and clinical perspectives of ADHD across the lifespan, and covered topics such as: risks and consequences of ADHD; new clinical guidelines for the diagnosis and management of ADHD; transition in patients with ADHD; ADHD and comorbid psychiatric conditions; and emerging directions for ADHD.

ADHD clinical guidelines

Videos from Meeting of Minds X (Madrid, Spain, 17-18 April, 2018), a scientific forum initiated, organised and funded by Shire, now part of Takeda


Day 1 – Advancing the science and clinical perspectives of ADHD across the life-course

Meeting of Minds 2018, Madrid, Spain, 17–18 April

Day 1 of Meeting of Minds 2018 brought the audience plenary sessions on advances in ADHD over the past decade, new clinical guidelines for ADHD, and challenges in the transition from child to adult mental health services.

Read more >



Day 2 – Advancing the science and clinical perspectives of ADHD across the life-course

Meeting of Minds 2018, Madrid, Spain, 17–18 April

Day 2 of Meeting of Minds 2018 brought the audience two parallel plenary sessions, which covered optimising the management of ADHD in children, adolescents and adults with comorbid psychiatric disorders, key publications from 2017/2018, and the future of ADHD management.

Read more >



A selection of clinical seminars – Advancing the science and clinical perspectives of ADHD across the life-course

Meeting of Minds 2018, Madrid, Spain, 17–18 April

Over the course of the 2-day meeting, delegates attended a series of clinical seminars on topics such as: ADHD and comorbid psychiatric disorders; psychopharmacology of ADHD medications; diagnostic issues and management of late-onset ADHD; ADHD treatment choice for children and adolescents; and ‘tips and tricks’ for greater success in patient consultations.

Read more >



Day 1 – Changes, challenges and complexities: ADHD across the life-course

Meeting of Minds 2017, The Hague, The Netherlands, 14–15 September

Day 1 of Meeting of Minds 2017 brought the audience exciting plenary sessions on the neurobiology of ADHD across the life-course; ADHD in girls and women; and the consequences of untreated ADHD.

Read more >



Day 2 – Changes, challenges and complexities: ADHD across the life-course

Meeting of Minds 2017, The Hague, The Netherlands, 14–15 September

Day 2 of Meeting of Minds 2017 brought the audience two parallel plenary sessions which covered the challenges and complexities of diagnosing and treating children/adolescents and adults with ADHD and psychiatric comorbid disorders; key publications in ADHD from the past year; ADHD and the impact on families; management strategies across the life-course; and sustaining optimal managent of ADHD.

Read more >



A selection of clinical seminars – Changes, challenges and complexities: ADHD across the life-course

Meeting of Minds 2017, The Hague, The Netherlands, 14–15 September

Across the 2-day meeting delegates were able to attend a range of clinical seminars which encompassed a wide range of subjects such as the new ASRS v1.2 screener, behavioural health in women, non-pharmacological and pharmacological treatment strategies, ADHD and psychiatric comorbidities in children, adolescents and adults, and strategies to help families living with ADHD. Here are some highlights.

Read more >





Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Takeda has no influence or control over the content of this third party website.

Continue Cancel